- Home
- GAUZ vs IMA Comparison
GAUZ vs IMA Comparison
Compare GAUZ & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GAUZ
- IMA
- Stock Information
- Founded
- GAUZ 2009
- IMA 2019
- Country
- GAUZ Israel
- IMA United States
- Employees
- GAUZ N/A
- IMA N/A
- Industry
- GAUZ Industrial Machinery/Components
- IMA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GAUZ Miscellaneous
- IMA Health Care
- Exchange
- GAUZ Nasdaq
- IMA Nasdaq
- Market Cap
- GAUZ 102.0M
- IMA 92.2M
- IPO Year
- GAUZ 2024
- IMA N/A
- Fundamental
- Price
- GAUZ N/A
- IMA $8.27
- Analyst Decision
- GAUZ Strong Buy
- IMA
- Analyst Count
- GAUZ 3
- IMA 0
- Target Price
- GAUZ $13.67
- IMA N/A
- AVG Volume (30 Days)
- GAUZ 44.2K
- IMA 87.8K
- Earning Date
- GAUZ 11-11-2025
- IMA 11-15-2025
- Dividend Yield
- GAUZ N/A
- IMA N/A
- EPS Growth
- GAUZ N/A
- IMA N/A
- EPS
- GAUZ N/A
- IMA N/A
- Revenue
- GAUZ $96,810,000.00
- IMA $4,300,000.00
- Revenue This Year
- GAUZ $22.59
- IMA N/A
- Revenue Next Year
- GAUZ $41.48
- IMA N/A
- P/E Ratio
- GAUZ N/A
- IMA N/A
- Revenue Growth
- GAUZ 7.87
- IMA N/A
- 52 Week Low
- GAUZ $4.54
- IMA $7.57
- 52 Week High
- GAUZ $13.00
- IMA $23.28
- Technical
- Relative Strength Index (RSI)
- GAUZ 62.21
- IMA N/A
- Support Level
- GAUZ $5.88
- IMA N/A
- Resistance Level
- GAUZ $6.80
- IMA N/A
- Average True Range (ATR)
- GAUZ 0.43
- IMA 0.00
- MACD
- GAUZ 0.12
- IMA 0.00
- Stochastic Oscillator
- GAUZ 100.00
- IMA 0.00
About GAUZ Gauzy Ltd. Ordinary Shares
Gauzy Ltd is a fully integrated light and vision control company. Its products include suspended particle device and liquid crystal materials for smart glass applications and AI-powered driver assistance systems, or ADAS, solutions including camera monitoring systems. The company's operating segments are Architecture, Automotive, Safety tech, and Aeronautics. Maximum revenue is generated from its Safety tech segment, which focuses on sales of driver assistance systems for buses, coaches, recreational vehicles, and specific vehicles, such as camera and motion sensor systems, smart mirrors, and safety doors. Geographically, it derives maximum revenue from other European countries (excluding France), followed by the United States, France, Asia, Israel, and other regions.
About IMA ImageneBio Inc. Common Stock
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.